ADVANCED CELL Financials

Please note, the presentation of ADVANCED CELL's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ADVANCED CELL's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ADVANCED CELL's management manipulating its earnings.

ADVANCED CELL's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ADVANCED CELL volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on ADVANCED CELL TECH correlated with the market. If Beta is less than 0 ADVANCED CELL generally moves in the opposite direction as compared to the market. If ADVANCED CELL Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ADVANCED CELL TECH is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ADVANCED CELL is generally in the same direction as the market. If Beta > 1 ADVANCED CELL moves generally in the same direction as, but more than the movement of the benchmark.